Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis.

Sci Rep · 2020 · PMC7434906 · PMID 32811969

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

DAS28 showed a trend to differ at baseline with class 1, the poor responding group having higher score than the other two groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.